Inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) combination commonly prescribed to treat chronic obstructive pulmonary disease (COPD). Therefore, we performed a meta-analysis on the impact of adding a long-acting muscarinic receptor antagonist (LAMA) to ICS/LABA combination in COPD.

Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple therapy in COPD

Matera, Maria Gabriella;
2019

Abstract

Inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) combination commonly prescribed to treat chronic obstructive pulmonary disease (COPD). Therefore, we performed a meta-analysis on the impact of adding a long-acting muscarinic receptor antagonist (LAMA) to ICS/LABA combination in COPD.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11591/402742
Citazioni
  • ???jsp.display-item.citation.pmc??? 34
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact